Patents by Inventor Hana KANTOR

Hana KANTOR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID STATE FORMS OF RELUGOLIX
    Publication number: 20220227784
    Abstract: The present disclosure provides solid state forms of Relugolix, crystalline forms of Relugolix, pharmaceutical compositions thereof, and pharmaceutical formulations thereof. Methods for producing these forms of Relugolix, pharmaceutical compositions, and pharmaceutical formulations are also provided.
    Type: Application
    Filed: April 6, 2022
    Publication date: July 21, 2022
    Inventors: Hana Kantor, Roman Gabriel, Pavel Kolesa, Alexandr Jegorov
  • Solid state forms of Relugolix
    Patent number: 11306104
    Abstract: The present disclosure provides solid state forms of Relugolix, crystalline forms of Relugolix, pharmaceutical compositions thereof, and pharmaceutical formulations thereof. Methods for producing these forms of Relugolix, pharmaceutical compositions, and pharmaceutical formulations are also provided.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: April 19, 2022
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Hana Kantor, Roman Gabriel, Pavel Kolesa, Alexandr Jegorov
  • RIBOCICLIB SALTS AND SOLID STATE FORMS THEREOF
    Publication number: 20220041598
    Abstract: The present disclosure relates to Ribociclib solid state forms, Ribociclib salts including Ribociclib succinate and solid state forms thereof, as well as processes for preparation thereof and pharmaceutical compositions thereof.
    Type: Application
    Filed: October 25, 2021
    Publication date: February 10, 2022
    Inventors: Helena Ceric, Elisa Vergani, Paolo S. Tiseni, Hana Kantor, Piero Paravidino, Nikolina Janton, Christian Galluzzo, Alexandr Jegorov
  • Ribociclib salts and solid state forms thereof
    Patent number: 11155545
    Abstract: The present disclosure relates to Ribociclib solid state forms, Ribociclib salts including Ribociclib succinate and solid state forms thereof, as well as processes for preparation thereof and pharmaceutical compositions thereof.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: October 26, 2021
    Assignee: Sicor—Societa Italiana Corticosteroid s.r.l.
    Inventors: Helena Ceric, Elisa Vergani, Paolo S. Tiseni, Hana Kantor, Piero Paravidino, Nikolina Janton, Christian Galluzzo, Alexandr Jegorov
  • IMPROVED PROCESSES FOR THE PREPARATION OF GUADECITABINE AND INTERMEDIATES THEREOF
    Publication number: 20210147466
    Abstract: Described are procedures and intermediates for the preparation of guadecitabine, and guadecitabine salts and solid state forms thereof.
    Type: Application
    Filed: July 11, 2018
    Publication date: May 20, 2021
    Inventors: Jana ROHACOVA, Jiri ZUREK, Hana KANTOR, Ales HUSEK
  • SOLID STATE FORMS OF RELUGOLIX
    Publication number: 20210017188
    Abstract: The present disclosure provides solid state forms of Relugolix, crystalline forms of Relugolix, pharmaceutical compositions thereof, and pharmaceutical formulations thereof. Methods for producing these forms of Relugolix, pharmaceutical compositions, and pharmaceutical formulations are also provided.
    Type: Application
    Filed: March 14, 2019
    Publication date: January 21, 2021
    Inventors: Hana Kantor, Roman Gabriel, Pavel Kolesa, Alexandr Jegorov
  • RIBOCICLIB SALTS AND SOLID STATE FORMS THEREOF
    Publication number: 20200190084
    Abstract: The present disclosure relates to Ribociclib solid state forms, Ribociclib salts including Ribociclib succinate and solid state forms thereof, as well as processes for preparation thereof and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 22, 2018
    Publication date: June 18, 2020
    Inventors: Helena Ceric, Elisa Vergani, Paolo S. Tiseni, Hana Kantor, Piero Paravidino, Nikolina Janton, Christian Galluzzo, Alexandr Jegorov
  • Solid state forms of selexipag
    Patent number: 10188648
    Abstract: The present disclosure relates to solid state forms of Selexipag, in particular selexipag forms IV and V, and processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: January 29, 2019
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Nidia Villalva, Ivon Cante, Martin Aybar, Angel Rodriguez, Alejandro Guillen Torres, Hana Kantor, Ales Gavenda, Hugo Herrera, Alexander Jegorov, Nydia Lopez
  • SOLID STATE FORMS OF SELEXIPAG
    Publication number: 20180214446
    Abstract: The present disclosure relates to solid state forms of Selexipag, in particular selexipag forms IV and V, and processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: September 2, 2016
    Publication date: August 2, 2018
    Inventors: Nidia VILLALVA, Ivon CANTE, Martin AYBAR, Angel RODRIGUEZ, Alejandro Guillen TORRES, Hana KANTOR, Ales GAVENDA, Hugo HERRERA, Alexander JEGOROV, Nydia LOPEZ